Seasoned private markets executive and investor focused on mid-market buyouts, operational transformation and value creation across industrials and business services. Frederic G Sauer combines deal execution and hands-on operating experience to lead growth initiatives, margin improvement and strategic carve-outs. Active in sponsor-backed transactions, board oversight and minority recapitalizations, brings a capital-allocation lens to portfolio governance and exit planning while engaging with management teams and limited partners across Europe and North America.
Seasoned private markets executive and investor focused on mid-market buyouts, operational transformation and value creation across industrials and business services. Frederic G Sauer combines deal execution and hands-on operating experience to lead growth initiatives, margin improvement and strategic carve-outs. Active in sponsor-backed transactions, board oversight and minority recapitalizations, brings a capital-allocation lens to portfolio governance and exit planning while engaging with management teams and limited partners across Europe and North America.
Focuses on mid‑market buyouts and sponsor-backed investments that prioritize operational transformation and margin improvement in industrials and business services. Employs a hands‑on, value‑creation orientation: active board engagement, strategic carve‑outs, and minority recapitalizations to align management and capital. Underwrites opportunities on cash‑flow resilience and operational upside, applying a capital‑allocation lens to portfolio governance and exit planning. Targets medium‑term, value‑driven outcomes across Europe and North America with disciplined risk controls and KPI‑led turnaround playbooks.
Focuses on mid‑market buyouts and sponsor-backed investments that prioritize operational transformation and margin improvement in industrials and business services. Employs a hands‑on, value‑creation orientation: active board engagement, strategic carve‑outs, and minority recapitalizations to align management and capital. Underwrites opportunities on cash‑flow resilience and operational upside, applying a capital‑allocation lens to portfolio governance and exit planning. Targets medium‑term, value‑driven outcomes across Europe and North America with disciplined risk controls and KPI‑led turnaround playbooks.
| Trades 419 | Longs Won 296/419 70% | Profit Factor 4.91 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $1.23M |
| Average Win $366,742.3 | Best Trade (Sep 01) $16.7M | Sharpe Ratio -182.7 |
| Average Loss -$179,617.59 | Worst Trade (Aug 31) -$7.13M | Z-Score 11.17 (100%) |
| Commissions $0 | Avg. Trade Length 1y 2m 5d | Expectancy $206,355.03 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 2,004 | 1,804 | 1,603 | 1,403 | 1,202 | 1,002 | 802 | 601 | 401 | 200 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 14,354 | $3.05M | $4.38M | - | $1.33M | 43.69% | -1.087% |
ABBV AbbVie Inc. | 6,102 | $1.05M | $1.51M | - | $464,099.64 | 44.24% | 0.0 |
ABT Abbott Laboratories | 12,675 | $1.32M | $1.39M | - | $73,641.84 | 5.59% | +1.013% |
AEE Ameren Corporation | 13,193 | $938,154.08 | $1.41M | - | $473,496.92 | 50.47% | 0.0 |
AFL Aflac Inc. | 4,225 | $377,334.75 | $515,196.5 | - | $137,861.75 | 36.54% | 0.0 |
AMZN Amazon.com Inc | 4,920 | $963,340.85 | $1.34M | - | $376,227.55 | 39.05% | -2.093% |
ARLP Alliance Resource Partners, L.P. | 43,600 | $1.16M | $1.08M | - | -$82,846.21 | -7.12% | 0.0 |
ARWR Arrowhead Pharmaceuticals Inc. | 65,831 | $4.36M | $5.87M | - | $1.51M | 34.72% | +1.03% |
ASML ASML Holding N.V. New York Registry Shares | 5,338 | $4.9M | $9.61M | - | $4.71M | 96.08% | +3.802% |
ATO Atmos Energy Corporation | 20,034 | $2.59M | $3.36M | - | $776,700.27 | 30.02% | 0.0 |
AVGO Broadcom Inc. | 10,046 | $3.53M | $4.24M | - | $716,941.67 | 20.33% | 0.0 |
AXP American Express Company | 600 | $202,950 | $203,315.99 | - | $365.99 | 0.18% | 0.0 |
BA Boeing Company | 1,904 | $346,547.49 | $444,088.96 | - | $97,541.47 | 28.15% | +0.193% |
BIIB Biogen Inc. | 39,571 | $8.43M | $8.2M | - | -$235,458.77 | -2.79% | 0.0 |
BMY Bristol-Myers Squibb Company | 17,512 | $735,017.19 | $1.14M | - | $400,460.89 | 54.48% | 0.0 |
BRK-B Berkshire Hathaway Inc. | 1,578 | $682,705.26 | $835,424.76 | - | $152,719.5 | 22.37% | 0.0 |
CAT Caterpillar Inc. | 575 | $223,221 | $481,608.5 | - | $258,387.5 | 115.75% | 0.0 |
CBSH Commerce Bancshares, Inc. | 11,804 | $630,562.69 | $692,304.6 | - | $61,741.91 | 9.79% | 0.0 |
CCJ Cameco Corporation | 54,950 | $3.12M | $5.35M | - | $2.23M | 71.54% | 0.0 |
CDNMF EGR Exploration Ltd. | 3,691 | $103.35 | $369.1 | - | $265.75 | 257.14% | 0.0 |